Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07133490) titled 'INTERACT Stomach-II' on Aug. 6.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Erasmus Medical Center

Condition: Peritoneal Metastases From Gastric Cancer

Intervention: Drug: intraperitoneal chemotherapy

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: October 1, 2025

Target Sample Size: 49

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07133490

Published by HT Digital Content Services with permission from Health Daily Digest....